This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurogenetics  • Genetic Counseling/ Testing/ Therapy  • Alert me on articles by topic  Social Bookmarking   What's this?

Implications for Diagnostic Strategies

Nils Peters, MD; Christian Opherk, MD; Tanja Bergmann; Mirna Castro, PhD; Jürgen Herzog, MD; Martin Dichgans, MD

Arch Neurol. 2005;62:1091-1094.

Background  Mutations in the NOTCH3 gene are the cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), which is an important cause of stroke in young adults. Mutations are typically located within epidermal growth factor–like repeat domains in the extracellular part of the Notch3 receptor. Identification of the mutation is critical for genetic counseling and testing of relatives at risk.

Objectives  To identify the spectrum of NOTCH3 mutations in CADASIL and to discuss the implications for diagnostic strategies.

Design  Screening for NOTCH3 mutations was performed in 125 unrelated German CADASIL patients with biopsy-proven disease by direct sequencing of exons coding for epidermal growth factor–like repeats. Results were compared with those of previously published studies.

Results  We detected 54 distinct mutations (117 missense mutations and 3 in-frame deletions) in 120 (96.0%) of the 125 patients. Of the mutations, 58.3% were located in exon 4 and 85.8% in exons 2 through 6. In 5 patients (4.0%), no mutation was identified.

Conclusions  Almost 90% of mutations could be detected within a few exons (exons 2-6). Thus, genetic testing should initially be focused on these exons, with some variation depending on the population in whom it is being performed. Yet, genetic testing for CADASIL is associated with a nameable proportion of false-negative results. Cases with a high index of clinical suspicion should be investigated by skin biopsy if genetic testing is negative.

Author Affiliations: Department of Neurology, Neurogenetics Laboratory, Klinikum Grosshadern, Ludwig-Maximilians University, Munich, Germany.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

CADASIL mutations enhance spontaneous multimerization of NOTCH3
Opherk et al.
Hum Mol Genet 2009;18:2761-2767.
ABSTRACT | FULL TEXT  

Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain
Monet-Lepretre et al.
Brain 2009;132:1601-1612.
ABSTRACT | FULL TEXT  

Neuropathological Correlates of Temporal Pole White Matter Hyperintensities in CADASIL
Yamamoto et al.
Stroke 2009;40:2004-2011.
ABSTRACT | FULL TEXT  

Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients
Tikka et al.
Brain 2009;132:933-939.
ABSTRACT | FULL TEXT  

The role of genetics in stroke
Francis et al.
Postgrad. Med. J. 2007;83:590-595.
ABSTRACT | FULL TEXT  

The archetypal R90C CADASIL-NOTCH3 mutation retains NOTCH3 function in vivo
Monet et al.
Hum Mol Genet 2007;16:982-992.
ABSTRACT | FULL TEXT  

Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL
Low et al.
Brain 2007;130:357-367.
ABSTRACT | FULL TEXT  

Heritability of MRI Lesion Volume in CADASIL: Evidence for Genetic Modifiers
Opherk et al.
Stroke 2006;37:2684-2689.
ABSTRACT | FULL TEXT  

Advances in Vascular Cognitive Impairment 2005
Chui and Skoog
Stroke 2006;37:323-325.
FULL TEXT